abstract |
The present invention is a method for treating and preventing ophthalmic diseases and disorders, which requires antagonist A or another pharmaceutically acceptable salt thereof, optionally in combination with another treatment. The method comprising administering to a subject. The present invention is also a method for treating and preventing ophthalmic diseases and disorders, wherein an anti-C5 agent (eg, ARC1905) is optionally combined with another treatment to a subject in need thereof. It also relates to said method comprising administering. [Selection] Figure 22 |